S 3553
117th Congress
Senate
Health
Government studies and investigations
Manufacturing
Medical research
Prescription drugs
Research administration and funding
Technology assessment
Agility in Manufacturing Preparedness Act
Introduced: February 2, 2022
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 2, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 2, 2022
Introduced in Senate
Plain-English summary
Agility in Manufacturing Preparedness Act
This bill requires the Department of Health and Human Services (HHS) to seek to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals to assess and make recommendations concerning U.S. capabilities for biopharmaceutical manufacturing and related matters. HHS must coordinate with the Biomedical Advanced Research and Development Authority on this contract.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1
Cosponsors
1